Comparative efficacy of Palbociclib and Everolimus with aromatase inhibitors in second line treatment of HR and HER2 negative metastatic breast cancer.

ABSTRACT:

SUBMITTER: Najafizade N 

PROVIDER: S-EPMC12834877 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature